Leveraging genetic interactions for adverse drug-drug interaction prediction.
Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization.
Identifying and targeting cancer-specific metabolism with network-based drug target prediction.
Critical period plasticity-related transcriptional aberrations in schizophrenia and bipolar disorder.
DigChem: Identification of disease-gene-chemical relationships from Medline abstracts.
A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data.
Timing of first-in-child trials of FDA-approved oncology drugs.
Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery.
Elucidating the druggability of the human proteome with eFindSite.